Showing results (61-70 of 114) with videos related to
Sort By:
Pageof 12
British Journal of Haematology|October 26, 2013
Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotypeHangseok Choi, Chulwon Jung, Sang Kyun Sohn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2011
Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotypeJun Ho Yi, Jungwon Huh, Hee-Jin Kim, et al.Lung Cancer (Amsterdam, Netherlands)|December 24, 2011
Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancerJin Ho Baek, Hawk Kim, Jong-Joon Ahn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabineJe-Hwan Lee, Young-Don Joo, Hawk Kim, et al.Annals of Hematology|January 13, 2016
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective studyJin Seok Kim, Dok Hyun Yoon, Seonyang Park, et al.Oncotarget|November 8, 2017
Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working PartyDa Jung Kim, Ho Sup Lee, Joon-Ho Moon, et al.Yonsei Medical Journal|December 17, 2013
Clinical outcomes and prognostic factors of empirical antifungal therapy with itraconazole in the patients with hematological malignancies: a prospective multicenter observational study in KoreaJin Seok Kim, June-Won Cheong, Ho Jin Shin, et al.The Oncologist|October 5, 2014
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study GroupTae Min Kim, Dong-Wan Kim, Yoon-Koo Kang, et al.Orphanet Journal of Rare Diseases|November 11, 2025
The Gaucher Earlier Diagnosis Consensus point-scoring system for children and young adults: a retrospective and prospective evaluation in KoreaSeung Min Hahn, Minseok Kim, Youna Kim, et al.Lung Cancer (Amsterdam, Netherlands)|November 17, 2007
Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinomaSu Jin Shin, Hawk Kim, Jin Ho Baek, et al.Pageof 12